Phibro Animal Health Overview

  • Year Founded
  • 1946

Year Founded

  • Status
  • Public

  • Employees
  • 2,605

Employees

  • Stock Symbol
  • PAHC

Stock Symbol

  • Investments
  • 9

  • Share Price
  • $33.30
  • (As of Friday Closing)

Phibro Animal Health General Information

Description

Phibro Animal Health Corp is a world-wide diversified animal health and mineral nutrition company. It strive to be a trusted partner with livestock producers, farmers, veterinarians and consumers who raise and care for farm and companion animals by providing solutions to help them maintain and enhance the health of their animals. It develop, manufacture and market products for food animals including poultry, beef and dairy cattle, swine, aquaculture and dogs. It has three segments Animal Health, Mineral Nutrition, and Performance Products. Majority of revenue comes from Animal Health segment. Animal health products are anti-bacterials, anticoccidials, nutritional specialty products, and vaccines, and vaccine adjuvants that help improve the animal's health.

Contact Information

Website
www.pahc.com
Formerly Known As
Philipp Brothers Chemicals
Ownership Status
Publicly Held
Financing Status
Formerly PE-Backed
Corporate Office
  • Glenpointe Centre East, 3rd Floor
  • 300 Frank West Burr Boulevard, Suite 21
  • Teaneck, NJ 07666-6712
  • United States
+1 (201)
Primary Industry
Other Commercial Products
Stock Exchange
NAS
Vertical(s)
Corporate Office
  • Glenpointe Centre East, 3rd Floor
  • 300 Frank West Burr Boulevard, Suite 21
  • Teaneck, NJ 07666-6712
  • United States
+1 (201)

Phibro Animal Health Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Phibro Animal Health Stock Performance

As of 20-Nov-2026, Phibro Animal Health’s stock price is $33.30. Its current market cap is $1.35B with 40.6M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$33.30 $34.08 $28.25 - $60.08 $1.35B 40.6M 231K $2.54

Phibro Animal Health Financials Summary

As of 30-Sep-2026, Phibro Animal Health has a trailing 12-month revenue of $1.54B.

In Thousands,
USD
TTM 30-Sep-2026 FY 2026 30-Jun-2026 FY 2025 30-Jun-2025 FY 2024 30-Jun-2024
EV 2,157,874 1,983,725 1,734,895 1,103,486
Revenue 1,540,974 1,518,093 1,296,215 1,017,679
EBITDA 233,352 230,972 144,225 64,590
Net Income 102,713 99,720 48,264 2,416
Total Assets 1,514,722 1,501,241 1,360,900 982,184
Total Debt 789,127 788,767 761,552 525,459
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Phibro Animal Health Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Phibro Animal Health‘s full profile, request access.

Request a free trial

Phibro Animal Health Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Phibro Animal Health Corp is a world-wide diversified animal health and mineral nutrition company. It strive to be a tru
Other Commercial Products
Teaneck, NJ
2,605 As of 2026

Lansing, MI
 

Cedar Rapids, IA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Phibro Animal Health Competitors (7)

One of Phibro Animal Health’s 7 competitors is Neogen (Lansing), a Formerly VC-backed company based in Lansing, MI.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Neogen (Lansing) Formerly VC-backed Lansing, MI
Diamond V Corporate Backed or Acquired Cedar Rapids, IA
Virbac Nederland Corporation Barneveld, Netherlands
Virbac Österreich Corporation Vienna, Austria
Zoetis Corporation Parsippany, NJ
You’re viewing 5 of 7 competitors. Get the full list »

Phibro Animal Health Patents

Phibro Animal Health Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4794544-A1 Use of zoalene in livestock Pending 16-Oct-2023
AU-2024283886-A1 Combination of bacterial strains to inhibit pathogens in animals Pending 06-Jun-2023
EP-4724077-A1 Combination of bacterial strains to inhibit pathogens in animals Pending 06-Jun-2023
US-20240407396-A1 Combination of bacterial strains to inhibit pathogens in animals Pending 06-Jun-2023
WO-2024254006-A1 Combination of bacterial strains to inhibit pathogens in animals Inactive 06-Jun-2023 A23K10/18
To view Phibro Animal Health’s complete patent history, request access »

Phibro Animal Health Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Phibro Animal Health Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Phibro Animal Health‘s full profile, request access.

Request a free trial

Phibro Animal Health Investments & Acquisitions (9)

Phibro Animal Health’s most recent deal was a Corporate Asset Purchase with Zoetis (Medicated Feed Additive Product Portfolio) for . The deal was made on 31-Oct-2024.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Zoetis (Medicated Feed Additive Product Portfolio) 31-Oct-2024 Corporate Asset Purchase Buildings and Property
DairyX (Israel) 01-May-2023 Early Stage VC Food Products
Osprey Biotechnics 01-Aug-2019 Merger/Acquisition Biotechnology
KoVax 06-Dec-2018 Merger/Acquisition Biotechnology
Biotay 11-Sep-2017 Merger/Acquisition Food Products
You’re viewing 5 of 9 investments and acquisitions. Get the full list »

Phibro Animal Health ESG

Risk Overview

Risk Rating

Updated November, 04, 2026

33.93 | High Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 13,593

Rank

Percentile

Pharmaceuticals

Industry

of 852

Rank

Percentile

Pharmaceuticals

Subindustry

of 354

Rank

Percentile

To view Phibro Animal Health’s complete esg history, request access »

Phibro Animal Health FAQs

  • When was Phibro Animal Health founded?

    Phibro Animal Health was founded in 1946.

  • Where is Phibro Animal Health headquartered?

    Phibro Animal Health is headquartered in Teaneck, NJ.

  • What is the size of Phibro Animal Health?

    Phibro Animal Health has 2,605 total employees.

  • What industry is Phibro Animal Health in?

    Phibro Animal Health’s primary industry is Other Commercial Products.

  • Is Phibro Animal Health a private or public company?

    Phibro Animal Health is a Public company.

  • What is Phibro Animal Health’s stock symbol?

    The ticker symbol for Phibro Animal Health is PAHC.

  • What is the current stock price of Phibro Animal Health?

    As of 20-Nov-2026 the stock price of Phibro Animal Health is $33.30.

  • What is the current market cap of Phibro Animal Health?

    The current market capitalization of Phibro Animal Health is $1.35B.

  • What is Phibro Animal Health’s current revenue?

    The trailing twelve month revenue for Phibro Animal Health is $1.54B.

  • Who are Phibro Animal Health’s competitors?

    Neogen (Lansing), Diamond V, Virbac Nederland, Virbac Österreich, and Zoetis are some of the 7 competitors of Phibro Animal Health.

  • What is Phibro Animal Health’s annual earnings per share (EPS)?

    Phibro Animal Health’s EPS for 12 months was $2.54.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process